{
    "key": "2013-0212",
    "name": "Dose 2 to dose 3 interval 8 wks-5 days in adolescent with two Recombivax not meeting rules for two dose adoles. 4th dose needed",
    "cdcTestId": "2013-0212",
    "changedInVersion": "4.2",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-06-18T08:03:52.749",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "43",
                "dateAdministered": "2020-03-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-ADULT"
            },
            {
                "cvx": "43",
                "dateAdministered": "2020-06-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-ADULT"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-03T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ],
        "seriesStatus": "Not complete"
    },
    "evaluationTestType": "All Valid: Forecast Test",
    "forecast": {
        "earliestDate": "2020-08-08T00:00:00",
        "forecastNum": "4",
        "pastDueDate": "2020-08-08T00:00:00",
        "recommendedDate": "2020-08-08T00:00:00"
    },
    "forecastTestType": "Recommended based on interval ",
    "generalDescription": "This test case describes when dose #3 of the Hep B Recomibivax vaccine is administered at an interval of 8 weeks - 5 days from dose #2 to an adolescent child, that the dose is valid, but a fourth dose is required.",
    "patient": {
        "dob": "2006-11-13T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "43",
                "dateAdministered": "2020-03-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-ADULT"
            },
            {
                "cvx": "43",
                "dateAdministered": "2020-06-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-ADULT"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-03T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ]
    },
    "reasonForChange": "V4.2: Updated Forecast Test Type to \"Recommended base on interval\"\nV4.1: Changed forecast to reflect new 4-dose guidance from CEB.\nV3.1: Changed dose 3 from not valid to valid due to recent clarifications.  Also changed test case name to reflect a 4th dose is required.",
    "testcaseName": "Dose 2 to dose 3 interval 8 wks-5 days in adolescent with two Recombivax not meeting rules for two dose adoles. 4th dose needed",
    "vaccineGroup": "HepB"
}